国家谈判药品“双通道”模式实施现状及优化建议——以S市为例  

Implementation Status and Optimized Suggestions of the"Dual-Channel"Model for National Negotiation Drugs——Taking S City as An Example

作　　者：张钰婉 谈在祥 卢亚娟 ZHANG Yu-wan;TAN Zai-xiang;LU Ya-juan(School of Management,Xuzhou Medical University,Xuzhou Jiangsu 221004,China;不详)

机构地区：[1]徐州医科大学管理学院,江苏徐州221004 [2]徐州医科大学附属医院,江苏徐州221006

出　　处：《卫生经济研究》2022年第4期15-18,23,共5页

摘　　要：目的:分析国家谈判药品“双通道”运行现状,并提出政策建议。方法:对S市国谈药品“双通道”政策进行梳理,以乳腺癌靶向药物“注射用曲妥珠单抗”为例,研究国谈药品的管理和使用情况。结果:S市国谈药品“双通道”模式实践较早,具有较好的借鉴意义,但在运行中存在一些共性问题。结论:医保部门要根据地方实际,从医院、医药、医保三个方面优化政策,打通国谈药品入院通道、保障药品质量、加强信息化建设,确保“双通道”模式的顺利落地。Objective To analyze the current situation of the"dual-channel"operation of national negotiated drugs,and to put forward policy suggestions.Methods This study sorted out the"dual-channel"policy of national negotiated drugs in S City,taking the breast cancer targeted drug"trastuzumab for injection"as an example to investigate the management and use of national negotiated drugs.Results"Dual-channel"model of national negotiated drugs in S City was earlier carried out.This practice was good to take as a reference,but it still had some common problems.Conclusion The medical insurance department should optimize the policies from the three aspects(hospital,medicine and medical insurance)according to the local actual situation.And it is suggested to open up the admission channel for national negotiated drugs,guarantee the quality,strengthen the construction of information technology,and ensure the successful implementation of the"dual-channel"model.

关 键 词：国家谈判药品 双通道 地方实践 

分 类 号：R19[医药卫生—卫生事业管理]